title: Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
authors: Servicio de Neurología, Hospital Ramón y Cajal, Madrid, Spain. joselopezsendon@hotmail.com
authors: Jose Luis López-Sendón
authors: JL
authors: Moreno
authors: Servicio de Medicina Interna, Hospital Puerta de Hierro, Madrid, Spain.
authors: Jose María
authors: JM
authors: Palau Fayos
authors: Servicio de Medicina Interna, Hospital Puerta de Hierro, Madrid, Spain.
authors: Alberto
authors: A
authors: Díaz de Santiago
authors: Servicio de Neurología, Hospital Ramón y Cajal, Madrid, Spain.
authors: Justo
authors: J
authors: García de Yébenes
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D003702:Delusions / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000150:complications*; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine